vs
Side-by-side financial comparison of CS Disco, Inc. (LAW) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $41.2M, roughly 1.7× CS Disco, Inc.). CS Disco, Inc. runs the higher net margin — -20.7% vs -49.0%, a 28.4% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 11.3%). CS Disco, Inc. produced more free cash flow last quarter ($255.0K vs $-84.7M).
CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
LAW vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $70.6M |
| Net Profit | $-8.5M | $-34.6M |
| Gross Margin | 75.1% | — |
| Operating Margin | -22.4% | -56.7% |
| Net Margin | -20.7% | -49.0% |
| Revenue YoY | 11.3% | 81958.1% |
| Net Profit YoY | 66.3% | 54.9% |
| EPS (diluted) | $-0.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | — | ||
| Q3 25 | $40.9M | $70.6M | ||
| Q2 25 | $38.1M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $36.3M | — | ||
| Q2 24 | $36.0M | — | ||
| Q1 24 | $35.6M | — |
| Q4 25 | $-8.5M | — | ||
| Q3 25 | $-13.7M | $-34.6M | ||
| Q2 25 | $-10.8M | — | ||
| Q1 25 | $-11.4M | — | ||
| Q4 24 | $-25.2M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $-10.8M | — | ||
| Q1 24 | $-10.6M | — |
| Q4 25 | 75.1% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.6% | — | ||
| Q1 25 | 74.1% | — | ||
| Q4 24 | 74.2% | — | ||
| Q3 24 | 73.1% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 75.1% | — |
| Q4 25 | -22.4% | — | ||
| Q3 25 | -35.3% | -56.7% | ||
| Q2 25 | -31.0% | — | ||
| Q1 25 | -34.4% | — | ||
| Q4 24 | -70.6% | — | ||
| Q3 24 | -30.0% | — | ||
| Q2 24 | -34.4% | — | ||
| Q1 24 | -34.7% | — |
| Q4 25 | -20.7% | — | ||
| Q3 25 | -33.4% | -49.0% | ||
| Q2 25 | -28.4% | — | ||
| Q1 25 | -31.1% | — | ||
| Q4 24 | -68.1% | — | ||
| Q3 24 | -25.3% | — | ||
| Q2 24 | -30.1% | — | ||
| Q1 24 | -29.7% | — |
| Q4 25 | $-0.13 | — | ||
| Q3 25 | $-0.22 | — | ||
| Q2 25 | $-0.18 | — | ||
| Q1 25 | $-0.19 | — | ||
| Q4 24 | $-0.43 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.6M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $128.1M | $503.0M |
| Total Assets | $173.6M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.6M | — | ||
| Q3 25 | $113.5M | $490.9M | ||
| Q2 25 | $114.5M | — | ||
| Q1 25 | $118.8M | — | ||
| Q4 24 | $129.1M | — | ||
| Q3 24 | $126.8M | — | ||
| Q2 24 | $130.0M | — | ||
| Q1 24 | $148.7M | — |
| Q4 25 | $128.1M | — | ||
| Q3 25 | $130.6M | $503.0M | ||
| Q2 25 | $137.9M | — | ||
| Q1 25 | $142.2M | — | ||
| Q4 24 | $147.5M | — | ||
| Q3 24 | $167.3M | — | ||
| Q2 24 | $170.9M | — | ||
| Q1 24 | $193.2M | — |
| Q4 25 | $173.6M | — | ||
| Q3 25 | $174.8M | $577.1M | ||
| Q2 25 | $164.9M | — | ||
| Q1 25 | $168.0M | — | ||
| Q4 24 | $180.3M | — | ||
| Q3 24 | $194.4M | — | ||
| Q2 24 | $198.0M | — | ||
| Q1 24 | $217.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $762.0K | $-84.6M |
| Free Cash FlowOCF − Capex | $255.0K | $-84.7M |
| FCF MarginFCF / Revenue | 0.6% | -120.1% |
| Capex IntensityCapex / Revenue | 1.2% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $762.0K | — | ||
| Q3 25 | $-979.0K | $-84.6M | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $-10.5M | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-650.0K | — | ||
| Q1 24 | $-7.3M | — |
| Q4 25 | $255.0K | — | ||
| Q3 25 | $-2.0M | $-84.7M | ||
| Q2 25 | $-5.2M | — | ||
| Q1 25 | $-11.0M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-8.0M | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | -5.0% | -120.1% | ||
| Q2 25 | -13.6% | — | ||
| Q1 25 | -30.1% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | -10.3% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -22.5% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.6% | 0.2% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.9% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
VRDN
Segment breakdown not available.
